Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
8.18
-0.03 (-0.37%)
Aug 26, 2026, 3:00 PM CST
Harbin Pharmaceutical Group Employees
Harbin Pharmaceutical Group had 10,039 employees as of December 31, 2025. The number of employees decreased by 141 or -1.39% compared to the previous year.
Employees
10,039
Change (1Y)
-141
Growth (1Y)
-1.39%
Revenue / Employee
1.59M CNY
Profits / Employee
30.86K CNY
Market Cap
20.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10,039 | -141 | -1.39% |
| Dec 31, 2024 | 10,180 | 327 | 3.32% |
| Dec 31, 2023 | 9,853 | -211 | -2.10% |
| Dec 31, 2022 | 10,064 | -142 | -1.39% |
| Dec 31, 2021 | 10,206 | -853 | -7.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tasly Pharmaceutical Group | 10,563 |
| Livzon Pharmaceutical Group | 8,878 |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6,003 |
| Kangmei Pharmaceutical | 5,492 |
| Jilin Aodong Pharmaceutical Group | 5,461 |
| Chengdu Kanghong Pharmaceutical Group | 4,470 |
| Shanghai Haoyuan Chemexpress | 4,195 |
| Hubei Jumpcan Pharmaceutical | 4,137 |
Harbin Pharmaceutical Group News
- 5 weeks ago - Why buyout funds, not IPOs, may define China’s next capital market cycle: Zhang Yichen - South China Morning Post
- 5 weeks ago - Citic Capital CEO on making China a financial powerhouse - South China Morning Post